| Literature DB >> 28788422 |
Suresh Kumar Kailasa1, Kuang-Hung Cheng2, Hui-Fen Wu3,4,5,6.
Abstract
Semiconductor quantum dots (QDs) or nanoparticles (NPs) exhibit very unusual physico-chemcial and optical properties. This review article introduces the applications of semiconductor nanomaterials (NMs) in fluorescence spectroscopy and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) for biomolecule analysis. Due to their unique physico-chemical and optical properties, semiconductors NMs have created many new platforms for investigating biomolecular structures and information in modern biology. These semiconductor NMs served as effective fluorescent probes for sensing proteins and cells and acted as affinity or concentrating probes for enriching peptides, proteins and bacteria proteins prior to MALDI-MS analysis.Entities:
Keywords: MALDI-MS; biomolecules; fluorescence spectroscopy; fluorescent and affinity probes; quantum dots
Year: 2013 PMID: 28788422 PMCID: PMC5452753 DOI: 10.3390/ma6125763
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Schematic diagram of density of states for 3D, 2D, 1D and 0D systems.
Figure 2Schematic representation of quantum dots (QDs)-based fluorescence ON/OFF mechanism for the detection of glutathione. Reprinted with permission from [30].
Figure 3Mechanism of DNA hybridization-detection System based on the QDs/Cy3-labeled DNA Förster (Fluorescence) Resonance Energy Transfer (FRET). Reprinted with permission from [70].
Figure 4(a) Interactions of CdTe QDs with rPrP; (b) Colorimetric qualitative detection of rPrP (6.7 µg mL−1) with CdTe QDs (1.0 × 10−6 mol L−1). The excitation wavelength of UV lamp was 302 nm. (i) CdTe QDs; (ii) CdTe QDs with BSA; (iii) CdTe QDs with His6-tagged MBP and (iv) CdTe QDs with rPrP. Reprinted with permission from [76].
Detection of biomolecules using semiconductor QDs-based fluorescence spectroscopic methods.
| Name of QDs | Name of the ligand | Diameter (nm) | Analytes | Detection limit (nM) | Reference |
|---|---|---|---|---|---|
| CdS:Mn/ZnS | DDTC | 5 | GSH | - | [ |
| CdS:Mn/ZnS | Amine group | 3.1 | TAT-peptide | - | [ |
| CdSe/ZnS | TGA | - | GSH | - | [ |
| CdS | MPA | 2–5 | - | [ | |
| Mn2+ZnS | Chitosan | 3–5 |
| - | [ |
| Mn2+ZnS and ZnS | Chitosan | 4.5 | PANC-1 cell | - | [ |
| CdS | TGA | 5 | DNA | - | [ |
| CdSe/ZnS | Peptides (GFE, KDE, LyP-1) | <10 | Tumors | - | [ |
| CdSe/ZnS | PBA, PEA, PMMA | 2.5–5.0 | Cancer cell | 10–100 | [ |
| CdSe | TOPO-sugars | 5–50 | Hela cell | - | [ |
| CdSe/ZnS | FA-PEA-PEG-750 | 13 | KB
| - | [ |
| CdSe/ZnS | Amino, carobxy and hydroxy groups PEG | - | Hela cell | - | [ |
| CdSe/ZnS | PEG- D-mannose, D-galactose, and D-galactosamine | 15–20 | Hepatocellular carcinoma cell line HepG2 | - | [ |
| QDs | Streptavidin | - | DNA | 4.8 × 10−15 | [ |
| CdTe | PDADMAC | - | DNA | - | [ |
| CdSe/ZnS | TOPO-DDA, TOPO-HDA | 3.3 | DNA | <1.0 × 10−9 | [ |
| CdSe/ZnS and iron oxide NPs | Streptavidin | 30 | DNA | 5.0 × 10−6 | [ |
| CdSe | TGA | 3–4 | 102 CFU/mL | [ | |
| CdSe | BSA | 5 | - | [ | |
| CdSe/ZnS | TGA-IgG | 6 |
| 102 cells/mL | [ |
| CdTe | MAA | ~3.4 | rPrP,
| 3.0 | [ |
| CdSe and CdSe/CdS | Citrate | - | cytochrome c, hemoglobin and myoglobin | - | [ |
| CdSe | Diethanolamine | 20 | BSA | - | [ |
| CdSe/ZnS | DSPE-PEG-2000 | 3.5–4 | BSA | - | [ |
| CdTe | TGA-neutral red-BSA | 3.1 | BSA | 1.97 | [ |
| CdTe | TGA | 2–3 | Chymotrypsin | - | [ |
| CdTe | MEA | - | HSA | 4.2 | [ |
| CdTe | MPA, NAC, GSH | - | HSA | - | [ |
| CdTe | MPA | 2–4.8 | HSA | - | [ |
| CdTe | MPA, L-Cys, GSH | 3.5 | BSA | - | [ |
| ZnS | L-Cys | 17 | BSA, HSA, γ-globulin, ovalbumin | 0.06–0.56 | [ |
| ZnSe | MAA | 25 | BSA | 30.3 | [ |
| CdSe | SFCA (
| - | Methionine and phenylalanine | 3000–4000 | [ |
Figure 5(a) Schematic representation of QDs as matrices for analysis of biocomplex structures by laser desorption ionization (LDI)-MS. Reprinted with permission from [90]; (b) Schematic diagram of peptide analysis by using hydroxycinnamic acid (CHCA), QDs along with CHCA and QDs based matrix-assisted laser desorption/ionization (MALDI) chip along with CHCA. Reprinted with permission from [91].
Figure 6MALDI-mass spectra of ubiquitin-like proteins in oyster mushroom by (a) ZnS-MPA NPs as the matrix and affinity probes; and (b) sinapic acid (SA) as the matrix. Peaks 1, 2, 3, and 4 at m/z 8063, 8384, 8593, and 10 666 are attributed to the ubiquitin-like protein (8.0 kDa), ubiquitin-like protein (8.3 kDa), ubiquitin (8.5 kDa), and ubiquitinlike protein (10.5 kDa), respectively. Reprinted with permission from [96].
Figure 7MALDI—mass spectra of transferrin using (a) SA; and (b) CdS QDs as the matrices. MALDI—mass spectra of bovine serum albumin (BSA) using (c) CdS QDs; and (d) SA as the matrices. Reprinted with permission from [99].
Figure 8Mass spectrum of BSA (5 µM) recorded using a matrix of HgTe nanostructures prepared in 300 mM ammonium citrate (pH 5.0). The signals at m/z 66 431, 33 216, 22 144, and 16 609 represent the adducts [M + H]+, [M + 2H]2+, [M + 3H]3+, and [M + 4H]4+, respectively. Inset: Mass spectrum of BSA obtained in SA matrixes (20 mg/mL in water/ACN (1:1, v/v) containing 0.1% TFA). The signals at m/z 132 862, 66 431, and 33 216 represent the adducts []+, [M + H]+, and [M + 2H]2+, respectively. Reprinted with permission from [90].
Overview of semiconductor nanomaterials-based MALDI-MS for biomolecules assays.
| Name of semiconductor NPs | Capping ligand | Analytes | Size (nm) | Detection limit | Technique | Reference |
|---|---|---|---|---|---|---|
| ZnS | MPA | Insulin, ubiquitin | - | 85–91 nM | MALDI-MS | [ |
| ZnS | N3 | Milk and ubiquitin-like proteins | 15 | - | MALDI-MS | [ |
| CdS | MPA | Peptides and proteins | 5 | - | LDI-MS | [ |
| CdS | MPA | Digested proteins | 5 | - | ESI-MS | [ |
| CdS | ATP, MUA | Peptides and proteins | 15–30 | 0.01–63 nM | MALDI-MS | [ |
| CdSe | MUA | Peptides and proteins | <10 | - | LDI-MS | [ |
| Cd2+-doped CNTs- CdS NPs | - | Cytochrome c and lysozyme | - | 1–7 nM | AP-MALDI-MS and MALDI-MS | [ |
| ZnSe | MPA | Leu-enk, Met-enk, HW6, substance P and Angio-II, and proteins (cytochrome c, myoglobin and lysozyme) | <5 | - | MALDI-MS | [ |
| ZnSe | MPA | Insulin, ubiquitin, cytochrome c, myoglobin and lysozyme | <10 | - | MALDI-MS | [ |
| Mn2+-ZnS | Cysteine | Peptides and proteins | 5.1 | ~1.0 pM | MALDI MS | [ |
| HgTe | MPA | Angio- I, Insulin, cytochrome c, BSA, IgG and
| 20 | 0.2–450 nM | SALDI- and MALDI-MS | [ |
| HgTe | MPA | α1-antitrypsin−trypsin and IgG−protein G complexes, | - | 0.5–3.0 µM | MALDI-MS | [ |
| CdS:Mn/ZnS | DDTC | Tryptic digests of cytochrome c, lysozyme and BSA | 6 ± 2 | - | MALDI-MS | [ |
| BaTiO3 | - | Tryptic digests of α- and β- casein and milk proteins | 30 | - | MALDI-MS | [ |
| SnO2 and TiO2 | PMMA | Myoglobin | 2–8 | 1 nM | SALDI-MS | [ |
| Au, TiO2, Se, CdTe QDs, Fe3O4, and Pt | - | Glutathione, Angio-I, insulin, cytochrome c and chymotrypsin | - | 140–4400 fM | SALDI-MS | [ |
| Mg(OH)2 | Oleic acid | Gramicidin D, valinomycin,
| <35 | - | MALDI-MS | [ |
| ZnO | - |
| - | - | MALDI-MS | [ |
| ZnO | - |
| - | - | MALDI-MS | [ |
| CdS | MPA | Extracellular polysaccharides in
| <5 | - | MALDI-MS | [ |
| TiO2 | - |
| - | - | MALDI-MS | [ |
| TiO2 | bacteria | - | - | MALDI-MS | [ | |
| ZrO2 and ZrO2-SiO2 | - | Leu-enk, Met-enk, HW6, and milk proteins | 20–30 | 75–105 fM | AP-MALDI-MS | [ |
| TiO2-dopamine and TiO2-CdS | - | Gramicidin D, myoglobin, cytochrome c, α- and β-caseins | 5–20 | 1 nM | MALDI-MS | [ |
| BaTiO3 | HOA | PLs and Hydrophobic proteins in
| 30–40 | 0.20–0.40 µM | MALDI-MS | [ |